| Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review G Georgiopoulos, N Makris, A Laina, F Theodorakakou, A Briasoulis, ... Cardio Oncology 5 (1), 1-21, 2023 | 23 | 2023 |
| Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: A prospective study E Kastritis, A Laina, G Georgiopoulos, M Gavriatopoulou, ... Leukemia 35 (5), 1418-1427, 2021 | 23 | 2021 |
| Free androgen index as a determinant of arterial stiffness in menopause: a mediation analysis I Lambrinoudaki, GA Georgiopoulos, F Athanasouli, E Armeni, D Rizos, ... Menopause 24 (6), 635-644, 2017 | 23 | 2017 |
| Metastatic Merkel cell carcinoma (MCC) of pancreas and breast: a unique case S Vernadakis, D Moris, A Bankfalvi, N Makris, GC Sotiropoulos World Journal of Surgical Oncology 11, 1-4, 2013 | 17 | 2013 |
| Cardiac mechanics in response to proteasome inhibition: a prospective study N Makris, G Georgiopoulos, A Laina, ME Tselegkidi, D Fotiou, N Kanellias, ... European Heart Journal-Cardiovascular Imaging 24 (5), 643-652, 2023 | 6 | 2023 |
| Daratumumab May Attenuate Cardiac Dysfunction Related to Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma: A Prospective Study E Terpos, K Stamatelopoulos, N Makris, G Georgiopoulos, ... Cancers 13 (20), 5057, 2021 | 5 | 2021 |
| Late T-wave inversion following resolution of non-ischemic acute pulmonary edema K Tampakis, N Makris, C Kontogiannis, M Spartalis, E Repasos, ... Clin Case Rep 7 (1), 224-226, 2018 | 3 | 2018 |
| Aortic hemodynamic parameters as predictors of incident or deteriorating hypertension during carfilzomib therapy in patients with relapsed multiple myeloma A Laina, G Georgiopoulos, N Makris, M Gavriatopoulou, E Papanagnou, ... European Heart Journal 42 (Supplement_1), ehab724. 2854, 2021 | 2 | 2021 |
| Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis A Briasoulis, D Bampatsias, I Petropoulos, A Rempakos, R Patras, ... European Heart Journal-Cardiovascular Imaging 25 (5), 698-707, 2024 | 1 | 2024 |
| Flow-Mediated Dilatation (FMD) and Aortic Blood Pressure May Predict Cardiovascular Adverse Events During Carfilzomib Therapy: A Prospective Study in Relapsed/Refractory … E Kastritis, A Laina, M Gavriatopoulou, G Georgiopoulos, D Fotiou, ... Clinical Lymphoma, Myeloma and Leukemia 19 (10), e262, 2019 | 1 | 2019 |
| Carfilzomib Induces Acute Endothelial Dysfunction Which Correlates with the Occurrence of Cardiovascular Events E Kastritis, A Laina, M Gavriatopoulou, G Georgiopoulos, ... Blood 132, 3247, 2018 | 1 | 2018 |
| Safety and efficacy of valsartan-sacubitril in a cohort of patients with symptomatic heart failure receiving small doses of ACE I Stamoulopoulos, A Ntalianis, E Papadopoulou, E Tseliou, S Sventzouri, ... EUROPEAN JOURNAL OF HEART FAILURE 20, 71-71, 2018 | 1 | 2018 |
| Fundamentals of the electrocardiogram and common cardiac arrhythmias Z Kotsialou, N Makris, S Gall Anaesthesia & Intensive Care Medicine, 2024 | | 2024 |
| Origin and regulation of the normal heartbeat N Makris, Z Kotsialou, S Gall Anaesthesia & Intensive Care Medicine, 2024 | | 2024 |
| ZAP (Zero-Fluoro-ALARA Procedures) EP: A UK Tertiary Centre Safety and Efficiency Evaluation N Makris, Z Kotsialou, N Elbanhawy, J Ariyaratnam, S Chalil, S Gall, ... European Heart Journal 44 (Supplement_2), ehad655. 326, 2023 | | 2023 |
| Global deterioration of cardiovascular mechanics by carfilzomib treatment is associated with proteasome activity in patients with relapsed multiple myeloma N Makris, A Laina, G Georgiopoulos, M Gavriatopoulou, ED Papanagnou, ... European Heart Journal 42 (Supplement_1), ehab724. 0749, 2021 | | 2021 |
| Protective Effects of Daratumumab on Carfilzomib-Related Cardiac Dysfunction in Patients with Relapsed Multiple Myeloma: Results from an Observational Study E Terpos, K Stamatelopoulos, N Makris, A Laina, M Gavriatopoulou, ... Blood 136, 17, 2020 | | 2020 |
| PS1394 FLOW-MEDIATED DILATATION AND AORTIC BLOOD PRESSURE PREDICT CARDIOVASCULAR ADVERSE EVENTS DURING CARFILZOMIB TREATMENT: A PROSPECTIVE STUDY IN PATIENTS WITH RELAPSED … E Kastritis, A Laina, M Gavriatopoulou, G Georgiopoulos, N Makris, ... HemaSphere 3 (S1), 639-640, 2019 | | 2019 |
| Small tolerated enalapril doses before ARNI administration predicts adverse events during ARNI up-titration A Ntalianis, IP Petropoulous, I Stamoulopoulos, E Repasos, G Maglaras, ... EUROPEAN JOURNAL OF HEART FAILURE 21, 228-228, 2019 | | 2019 |
| P1554 A non-invasive vascular multi-marker approach for the detection of coronary artery disease and future adverse events in high cardiovascular risk patients G Georgiopoulos, M Lavda, T Papaioannou, A Laina, S Georgiou, ... European Heart Journal 39 (suppl_1), ehy565. P1554, 2018 | | 2018 |
